Raphael P. Viscidi

17.4k citations

230 papers · 13.2k indexed · 2 hit papers · h-index 58

Impact in

Otorhinolaryngology top 0.05%
- Head and Neck Cancer Studies
Microbiology top 0.2%
- Reproductive tract infections research

Papers in

Virology 29
- HIV Research and Treatment 23
Microbiology 25
- Reproductive tract infections research 25

Co-authors: Maura L. Gillison Gypsyamber DʼSouza William H. Westra Aimée R. Kreimer Michael Pawlita Carole Fakhry Wayne M. Koch Robert H. Yolken
Journals: The Journal of Infectious Diseases (16 papers)Journal of Clinical Microbiology (16 papers)Cancer Epidemiology Biomarkers & Prevention (14 papers)Clinical and Vaccine Immunology (9 papers)International Journal of Cancer (9 papers)
Partner nations: United States Italy China

In The Last Decade

Raphael P. Viscidi

230 papers receiving 12.8k citations

Hit Papers

align trajectories log scale

Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers 2008 · 1.1k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 JNCI Journal of the National Cancer Institute
2007 New England Journal of Medicine

Peers

Countries citing papers authored by Raphael P. Viscidi

Since Specialization

Citations

This map shows the geographic impact of Raphael P. Viscidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael P. Viscidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael P. Viscidi more than expected).

Fields of papers citing papers by Raphael P. Viscidi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael P. Viscidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael P. Viscidi. The network helps show where Raphael P. Viscidi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raphael P. Viscidi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raphael P. Viscidi Line = papers co-authored together Raphael P. Viscidi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Age‐related transcript changes in type I interferon signaling in children and adolescents with long COVID European Journal of Immunology ·Gabriella Pravettoni, Enrica Mancino, Raffaella Nenna, Roger Coomer, Federica Frasca, Safira Aisha Putri, Cherrie Kwok, Laura Petrarca, Debarshi Guha, Luigi Matera, Greta Di Mattia, Beniamino Caputo, Guido Antonelli, Alessandra Pierangeli, Raphael P. Viscidi, Fabio Midulla, Carolina Scagnolari	2024	3
2	MPXV infection impairs IFN response but is partially sensitive to IFN-γ antiviral effect Medical Microbiology and Immunology ·Licia Bordi, Safira Aisha Putri, Federica Frasca, Valentina Mazzotta, Paola Mazzetti, Gabriella Pravettoni, Gabriella d’Ettorre, Guido Antonelli, Mauro Pistello, Andrea Antinori, Raphael P. Viscidi, Fabrizio Maggi, Paige Ellis, Carolina Scagnolari	2024	5
3	Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming International Journal of Molecular Sciences ·Raphael P. Viscidi, Pei Huaiquan, Ioannis Bossis	2023	1
4	Persistent Toxoplasma Infection of the Brain Induced Neurodegeneration Associated with Activation of Complement and Microglia Infection and Immunity ·Li Ye, Emily G. Severance, Raphael P. Viscidi, Robert H. Yolken, Jianchun Xiao	2019	50
5	Antibody Response to Merkel Cell Polyomavirus Associated with Incident Lymphoma in the Epilymph Case–Control Study in Spain Cancer Epidemiology Biomarkers & Prevention ·Clàudia Robles, Jeffrey L. McClellan, Delphine Casabonne, Eva González‐Barca, Ramón Bosch, Yolanda Benavente, Raphael P. Viscidi, Sílvia de Sanjosé	2012	10
6	Seroprevalence of Human Papillomavirus (HPV) Type 6 and 16 Vary by Anatomic Site of HPV Infection in Men Cancer Epidemiology Biomarkers & Prevention ·Beibei Lu, Raphael P. Viscidi, Yougui Wu, Alan G. Nyitray, Luisa L. Villa, Eduardo Lazcano‐Ponce, Roberto J. Carvalho da Silva, Maria Luiza Baggio, Manuel Quiterio, Jorge Salmerón, Dañelle C. Smith, Martha Abrahamsen, Mary Papenfuss, Anna R. Giuliano	2012	40
7	The Correlation Between Human Papillomavirus Positivity and Abnormal Cervical Cytology Result Differs by Age Among Perimenopausal Women Journal of Lower Genital Tract Disease ·Anne F. Rositch, Michelle I. Silver, Anne E. Burke, Raphael P. Viscidi, Kathryn Chang, Shane Chern, Wen Shen, Patti E. Gravitt	2012	23
8	High-Risk Human Papillomavirus Reactivation in Human Immunodeficiency Virus–Infected Women Obstetrics and Gynecology ·Regan N. Theiler, Sherry L. Farr, John M. Karon, Pangaja Paramsothy, Raphael P. Viscidi, Ann Duerr, Susan Cu‐Uvin, Jack D. Sobel, Keerti V. Shah, Robert S. Klein, Denise J. Jamieson	2010	56
9	No role for human papillomavirus in esophageal squamous cell carcinoma in China International Journal of Cancer ·Jill Koshiol, Wenqiang Wei, Aimée R. Kreimer, Wen Chen, Patti E. Gravitt, Jiansong Ren, Christian C. Abnet, (unknown), Farin Kamangar, Dongmei Lin, Magnus von Knebel Doeberitz, Yu Zhang, Raphael P. Viscidi, 由香利倉本, Maura L. Gillison, Mark J. Roth, Zhiwei Dong, Esther Kim, Philip R. Taylor, You‐Lin Qiao, Sanford M. Dawsey	2009	61
10	Mechanisms of HPV transmission in the era of HPV prevention vaccines Salud Pública de México ·Anna R. Giuliano, Raphael P. Viscidi	2007	1
11	Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysis BMC Evolutionary Biology ·Marcos Pérez‐Losada, Keith A. Crandall, Margaret C. Bash, Michael Dan, Jonathan M. Zenilman, Raphael P. Viscidi	2007	13
12	B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88 The Journal of Immunology ·Rongcun Yang, F. Murillo, Rogério Gondim COSTA, Richard L. Blosser, William H. Yutzy, Satoshi Uematsu, Kiyoshi Takeda, Shizuo Akira, Raphael P. Viscidi, Richard B.S. Roden	2005	70
13	Human Papillomavirus Type-16 Virus-Like Particles Activate Complementary Defense Responses in Key Dendritic Cell Subpopulations The Journal of Immunology ·Rongcun Yang, F. Murillo, Elena Pacita Lois Garrido, William H. Yutzy, Satoshi Uematsu, Kiyoshi Takeda, Shizuo Akira, Raphael P. Viscidi, Richard B.S. Roden	2004	17
14	A survey of human papillomavirus 16 antibodies in patients with epithelial cancers European Journal of Cancer Prevention ·Howard D. Strickler, Mark Schiffman, K. V. Shah, Charles S. Rabkin, Seong-Hwa Lee, Sholom Wacholder, Barbara Clayman, Raphael P. Viscidi	1998	73
15	Absence of Recoverable Infectious Virus and Unique Immune Responses in an Asymptomatic HIV ⁺ Long-Term Survivor AIDS Research and Human Retroviruses ·David H. Schwartz, Usha Sharma, Michael Busch, Kent J. Weinhold, Thomas J. Matthews, Judy Lieberman, Deborah L. Birx, Suraj KUMAR, Joseph B. Margolick, Thomas C. Quinn, Brian M. Davis, Omar Bagasra, Roger J. Pomerantz, Raphael P. Viscidi	1994	63
16	Antibodies to Recombinant gp160 in Mucosal Secretions and Sera of Persons Infected with HIV-1 and Seronegative Vaccine Recipients AIDS Research and Human Retroviruses ·Ann W. Funkhouser, M L Clements, Vladimir Petrovich Mitin, K. Jacobitz, Raphael P. Viscidi	1993	13
17	Serologic response in human papillomavirus‐associated invasive cervical cancer International Journal of Cancer ·Raphael P. Viscidi, Yeping Sun, 鏡一郎畔蒜, F. Xavier Bosch, Núbia Muñóz, Keerti V. Shah	1993	56
18	Gene Typing of Chlamydia trachomatis by Polymerase Chain Reaction and Restriction Endonuclease Digestion Sexually Transmitted Diseases ·M.Ya. Rozkin, Ashfaque Husain, C. H. Kircher, Edward W. Hook, Raphael P. Viscidi, Thomas C. Quinn	1992	2
19	Characterization of Serum Antibody Responses to Recombinant HIV-1 gp160 Vaccine by Enzyme Immunoassay AIDS Research and Human Retroviruses ·Raphael P. Viscidi, Edward F. Ellerbeck, Leslie Garrison, K Midthun, M L Clements, Barbara Clayman, B. F. Fernie, G. L. Smith	1990	15
20	Enzyme Immunoassay for Detection of Hybrids Between PCR-Amplified HIV-1 DNA and a RNA Probe: PCR-EIA AIDS Research and Human Retroviruses ·François Coutlée, J. n. Gassita, Ashfaque Husain, Kumudini Mayur, Robert H. Yolken, Raphael P. Viscidi	1990	26

About Raphael P. Viscidi

Raphael P. Viscidi is a scholar working on Virology, Microbiology, Epidemiology, Otorhinolaryngology and Infectious Diseases, having authored 230 papers that have together received 13.2k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (88 papers), Polyomavirus and related diseases (47 papers), Genital Health and Disease (33 papers), Hepatitis B Virus Studies (30 papers), Full-Duplex Wireless Communications (30 papers), Antenna Design and Analysis (26 papers), Reproductive tract infections research (25 papers) and HIV Research and Treatment (23 papers). The work is most often cited by research in Otorhinolaryngology (2.9k citations), Microbiology (1.2k citations), Virology (890 citations), Epidemiology (5.9k citations) and Periodontics (695 citations). Raphael P. Viscidi has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Maura L. Gillison, Gypsyamber DʼSouza, William H. Westra, Aimée R. Kreimer, Michael Pawlita, Carole Fakhry, Wayne M. Koch, Robert H. Yolken, Elizabeth A. Sugar and Patti E. Gravitt. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Clinical Microbiology, Cancer Epidemiology Biomarkers & Prevention, Clinical and Vaccine Immunology and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact